Despite massive success, a new report states 2023's Hogwarts Legacy won't receive an expansion or a Definitive Edition re-release originally planned for later this year. Neither of these projects ...

The Hogwarts Legacy DLC apparently would have reintegrated cut content from the base game (Warner Bros.) Warner Bros. has opted to abandon its DLC plans for Hogwarts Legacy, meaning focus will ...

The team behind Hogwarts Legacy has "canceled a planned expansion" for the game, effectively killing the Hogwarts Legacy DLC that had been heavily rumoured last year. But there is good news ...

The dose administered to the fourth cohort, as originally planned ... results and results from TransCode's Phase 0 clinical trial. "Commencement of treatment in Cohort 4 has been our vision ...

Dana Chandler, convicted of two 2002 murders, will be assisted by her 13th attorney, David Eugene McDonald, in seeking a fourth trial. McDonald, a graduate of Washburn Law School, has been ...

Attorney David Eugene McDonald, of Olathe-based Rivera Law, LLC, has been appointed standby counsel to aid Dana Chandler as she seeks a fourth trial after being convicted of two 2002 Topeka ...

First patient in Cohort four has been treated with TTX-MC138 Ten patients have been treated with TTX-MC138 at escalating dose levels Additional patients being evaluated for eligibility for ...

The dose administered to the fourth cohort, as originally planned in the clinical ... consistent with preclinical results and results from TransCode's Phase 0 clinical trial. "Commencement of ...

The dose administered to the fourth cohort, as originally planned ... results and results from TransCode's Phase 0 clinical trial. "Commencement of treatment in Cohort 4 has been our vision ...

The trial’s primary objective during this dose-escalation phase is to assess the safety and tolerability of TTX-MC138. The subsequent dose-expansion phase will further evaluate its safety ...